Methods. We have recently synthesized a novel proteasome inhibitor (BU-32) and tested its growth inhibitory effects in different breast cancer cells including MCF-7, MDA--231, and SKBR3 by in vitro cytotoxicity and proteasomal inhibition assays.The apoptotic potential of BU32 was tested using flow cytometry and analyzing cell cycle regulatory proteins.
WhatsApp: +86 18221755073